The TRIF-dependent signaling pathway is not required for acute cerebral ischemia/reperfusion injury in mice

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 678-683

  Hua, Fang ^a   Wang, Jun ^a   Sayeed, Iqbal ^a   Ishrat, Tauheed ^a   Atif, Fahim ^a   Stein, Donald G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral ischemia reperfusion; Mouse; TLRs; TRIF

Indexed keywords

BETA ACTIN; I KAPPA B ALPHA; I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; PHOSPHOTRANSFERASE; TANK BINDING KINASE 1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE;

ACUTE DISEASE; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; BRAIN; BRAIN ISCHEMIA; I-KAPPA B KINASE; MICE; MICE, KNOCKOUT; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

MUS;

EID: 70449707127     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.027     Document Type: Article

References (29)

1. De Simoni M.G., Milia P., Barba M., De Luigi A., Parnetti L., and Gallai V. The inflammatory response in cerebral ischemia: focus on cytokines in stroke patients. Clin. Exp. Hypertens. 24 (2002) 535-542
2. Stoll G. Inflammatory cytokines in the nervous system: multifunctional mediators in autoimmunity and cerebral ischemia. Rev. Neurol. 158 (2002) 887-891
3. Lehnardt S., Lehmann S., Kaul D., Tschimmel K., Hoffmann O., Cho S., Krueger C., Nitsch R., Meisel A., and Weber J.R. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J. Neuroimmunol. 190 (2007) 28-33
4. Cao C.X., Yang Q.W., Lv F.L., Cui J., Fu H.B., and Wang J.Z. Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem. Biophys. Res. Commun. 353 (2007) 509-514
5. Hua F., Ma J., Ha T., Xia Y., Kelley J., Williams D.L., Kao R.L., Browder I.W., Schweitzer J.B., Kalbfleisch J.H., and Li C. Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J. Neuroimmunol. 190 (2007) 101-111
6. Hua F., Ma J., Ha T., Kelley Y.J., Williams D.L., Kao R.L., Kalbfleisch J.H., Browder I.W., and Li C. Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury. J. Neuroimmunol. 199 (2008) 75-82
7. Hua F., Ma J., Ha T., Kelley J.L., Kao R.L., Schweitzer J.B., Kalbfleisch J.H., Williams D.L., and Li C. Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice. Brain Res. 1262 (2009) 100-108
8. Aderem A., and Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 406 (2000) 782-787
9. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2 (2001) 675-680
10. Anderson K.V. Toll signaling pathways in the innate immune response. Curr. Opin. Immunol. 12 (2000) 13-19
11. Chuang T.H., and Ulevitch R.J. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta 1518 (2001) 157-161
12. Du X., Poltorak A., Wei Y., and Beutler B. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur. Cytokine Network 11 (2000) 362-371
13. Sandor F., and Buc M. Toll-like receptors. I. structure, function and their ligands. Folia Biol. (Praha) 51 (2005) 148-157
14. Akira S., and Takeda K. Toll-like receptor signaling. Nat. Rev. Immunol. 4 (2004) 499-511
15. Hoshino K., Kaisho T., Iwabe T., Takeuchi O., and Akira S. Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation. Int. Immunol. 14 (2002) 1225-1231
16. Toshchakov V., Jones B.W., Perera P.Y., Thomas K., Cody M.J., Zhang S., Williams B.R., Major J., Hamilton T.A., Fenton M.J., and Vogel S.N. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3 (2002) 392-398
17. Hoebe K., Du X., Georgel P., Janssen E., Tabeta K., Kim S.O., Goode J., Lin P., Mann N., Mudd S., Crozat K., Sovath S., Han J., and Beutler B. Identification of Lps2 as a key transducer of MyD88-independent TIR signaling. Nature 424 (2003) 743-748
18. Marsh B., Stevens S.L., Packard A.E., Gopalan B., Hunter B., Leung P.Y., Harrington C.A., and Stenzel-Poore M.P. Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J. Neurosci. 29 (2009) 9839-9849
19. Garcia J.H., Wagner S., Liu K.F., and Hu X.J. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Stroke 26 (1995) 627-634
20. Shimamura N., Matchett G., Yatsushige H., Calvert J.W., Ohkuma H., and Zhang J. Inhibition of integrin alphavbeta3 ameliorates focal cerebral ischemic damage in the rat middle cerebral artery occlusion model. Stroke 37 (2006) 1902-1909
21. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., and Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4 (2003) 491-496
22. Hoshino K., Kaisho T., Iwabe T., Takeuchi O., and Akira S. Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation. Int. Immunol. 14 (2002) 1225-1231
23. Porter A.G., and Jänicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6 (1999) 99-104
24. Nurmi A., Lindsberg P.J., Koistinaho M., Zhang W., Juettler E., Karjalainen-Lindsberg M.L., Weih F., Frank N., Schwaninger M., and Koistinaho J. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 35 (2004) 987-991
25. Kaushal V., and Schlichter L.C. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J. Neurosci. 28 (2008) 2221-2230
26. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., and Schwaninger M. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5 (1999) 554-559
27. Stevens S.L., Ciesielski T.M., Marsh B.J., Yang T., Homen D.S., Boule J.L., Lessov N.S., Simon R.P., and Stenzel-Poore M.P. Toll-like receptor 9: a new target of ischemic preconditioning in the brain. J. Cereb. Blood Flow Metab. 28 (2008) 1040-1047
28. Hickey E.J., You X., Kaimaktchiev V., Stenzel-Poore M., and Ungerleider R.M. Lipopolysaccharide preconditioning induces robust protection against brain injury resulting from deep hypothermic circulatory arrest. J. Thorac. Cardiovasc. Surg. 133 (2007) 1588-1596
29. Kawai T., Takeuchi O., Fujita T., Inoue J., Muhlradt P.F., Sato S., Hoshino K., and Akira S. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167 (2001) 5887-5894